Related Experiment Video
Updated: Jun 12, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Robot-assisted adrenal-sparing surgery for pheochromocytoma: initial experience
Narmada P Gupta1, Rishi Nayyar, Prabhjot Singh
1Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. narmadagupta@hotmail.com
Journal of Endourology
|May 25, 2010
Summary
Robot-assisted surgery for pheochromocytoma is feasible and safe. This minimally invasive approach allows for adrenal sparing and effective tumor removal with minimal complications.
Area of Science:
- Minimally Invasive Surgery
- Surgical Oncology
- Endocrinology
Background:
- Pheochromocytoma, a neuroendocrine tumor, requires careful surgical management.
- Traditional surgical approaches may carry risks of complications and extensive recovery.
- Robotic surgical systems offer potential advantages in precision and control.
Purpose of the Study:
- To evaluate the feasibility and safety of robotic-assisted adrenalectomy for pheochromocytoma.
- To describe the surgical technique using the da Vinci S robotic system.
- To report initial clinical experience and outcomes.
Main Methods:
- Four patients with adrenal pheochromocytoma underwent robotic transperitoneal adrenalectomy.
- Standard preoperative preparation and intraoperative monitoring were employed.
- Adrenal parenchyma sparing was a key surgical objective.
Main Results:
- Mean operative time was 77.5 minutes, with average blood loss of 97.5 mL.
- No perioperative complications or conversions to open surgery occurred.
- All resections were oncologically complete, with a mean follow-up of 9 months showing no recurrence.
Conclusions:
- Robot-assisted adrenalectomy for pheochromocytoma is a feasible and safe option.
- The technique allows for effective tumor removal while preserving healthy adrenal tissue.
- Further long-term studies are warranted to confirm oncologic outcomes.
